AIM: To investigate whether hepatitis B virus (HBV) exacerbates hepatic cholesterol accumulation, and explore the underlying mechanisms. METHODS: HepG2 cells were infected with adenovirus (Ad) containing 1.3-fold overlength HBV genome. Real-time polymerase chain reaction and Western blotting were used to measure mRNA and protein expression of target genes. Cholesterol accumulation was measured by fluorescence microscopy. Cell toxicity due to Ad-HBV treatment was determined by the mitochondrial tetrazolium assay. The protein levels of toll-like receptors (TLRs) were determined by Western blotting. RESULTS: Ad-HBV increased hepatic cholesterol accumulation and enhanced the mRNA and protein levels of low-density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMGCoAr) mRNA and protein expression in HepG2 cells. In addition, these inductive effects were partly offset by suppressing TLR2 expression levels by small interfering RNA in HepG2 cells. CONCLUSION: Ad-HBV increases LDLR and HMGCoAr expression, resulting in exacerbated cholesterol accumulation in HepG2 cells, which was mediated via the TLR2 pathway.
AIM: To investigate whether hepatitis B virus (HBV) exacerbates hepatic cholesterol accumulation, and explore the underlying mechanisms. METHODS: HepG2 cells were infected with adenovirus (Ad) containing 1.3-fold overlength HBV genome. Real-time polymerase chain reaction and Western blotting were used to measure mRNA and protein expression of target genes. Cholesterol accumulation was measured by fluorescence microscopy. Cell toxicity due to Ad-HBV treatment was determined by the mitochondrial tetrazolium assay. The protein levels of toll-like receptors (TLRs) were determined by Western blotting. RESULTS: Ad-HBV increased hepatic cholesterol accumulation and enhanced the mRNA and protein levels of low-density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMGCoAr) mRNA and protein expression in HepG2 cells. In addition, these inductive effects were partly offset by suppressing TLR2 expression levels by small interfering RNA in HepG2 cells. CONCLUSION: Ad-HBV increases LDLR and HMGCoAr expression, resulting in exacerbated cholesterol accumulation in HepG2 cells, which was mediated via the TLR2 pathway.
Entities:
Keywords:
3-hydroxy-3-methylglutharyl-coenzyme A reductase; Hepatitis B virus; Low-density lipoprotein receptor; Toll-like receptors
Authors: S Kiechl; G Egger; M Mayr; C J Wiedermann; E Bonora; F Oberhollenzer; M Muggeo; Q Xu; G Wick; W Poewe; J Willeit Journal: Circulation Date: 2001-02-27 Impact factor: 29.690
Authors: Sabrina Pagano; Alessandra Magenta; Marco D'Agostino; Francesco Martino; Francesco Barillà; Nathalie Satta; Miguel A Frias; Annalisa Ronca; François Mach; Baris Gencer; Elda Favari; Nicolas Vuilleumier Journal: J Clin Med Date: 2019-11-21 Impact factor: 4.241
Authors: Elisabeth M Haberl; Thomas S Weiss; Georg Peschel; Kilian Weigand; Nikolai Köhler; Josch K Pauling; Jürgen J Wenzel; Marcus Höring; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler Journal: Int J Mol Sci Date: 2021-05-18 Impact factor: 5.923